Valproic acid suppresses collagen by selective regulation of Smads in conjunctival fibrosis

Novel Insight into the Inflammatory and Cellular Responses Following Experimental Glaucoma Surgery: A Roadmap for Inhibiting Fibrosis

(2013) L.-F. Seet et al.   CURRENT MOLECULAR MEDICINE

Molecular basis of organ fibrosis: Potential therapeutic approaches

(2013) Asish K Ghosh et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Comparison of trichostatin A and valproic acid treatment regimens in a mouse model of kidney fibrosis

(2013) Katrien Van Beneden et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Transforming growth factor β1 inhibits bone morphogenic protein (BMP)-2 and BMP-7 signaling via upregulation of Ski-related novel protein N (SnoN): possible mechanism for the failure of BMP therapy?

(2012) Sabrina Ehnert et al.   BMC Medicine

Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts

(2012) J.-S. Cho et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Surgical management of glaucoma: a review

(2012) William H Morgan et al.   CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

Valproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results

(2012) Sharon Berendsen et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Specific interactions between Smad proteins and AP-1 components determine TGFβ-induced breast cancer cell invasion

(2012) A Sundqvist et al.   ONCOGENE

Identifying an uptake mechanism for the antiepileptic and bipolar disorder treatment valproic acid using the simple biomedical model Dictyostelium

(2011) N. Terbach et al.   JOURNAL OF CELL SCIENCE

In vitro analyses of the anti-fibrotic effect of SPARC silencing in human Tenon’s fibroblasts: comparisons with mitomycin C

(2011) Li-Fong Seet et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Dynamic interplay between the collagen scaffold and tumor evolution

(2010) Mikala Egeblad et al.   CURRENT OPINION IN CELL BIOLOGY

Histone Deacetylase: A Potential Therapeutic Target for Fibrotic Disorders

(2010) M. Pang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Valproate and Bone Loss: iTRAQ Proteomics Show that Valproate Reduces Collagens and Osteonectin in SMA Cells

(2010) Heidi R. Fuller et al.   JOURNAL OF PROTEOME RESEARCH

Valproic Acid Activates the PI3K/Akt/mTOR Pathway in Muscle and Ameliorates Pathology in a Mouse Model of Duchenne Muscular Dystrophy

(2009) Praveen B. Gurpur et al.   AMERICAN JOURNAL OF PATHOLOGY

Transforming Growth Factor-β1 Up-Regulation of Human α1(I) Collagen Is Mediated by Sp1 and Smad2 Transacting Factors

(2009) Polina Sysa et al.   DNA AND CELL BIOLOGY

Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cellsin vitroandin vivo

(2009) Inge Mannaerts et al.   HEPATOLOGY

Homeobox Gene Prx1 Is Expressed in Activated Hepatic Stellate Cells and Transactivates Collagen α1(I) Promoter

(2008) Feng Jiang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

How the Smads regulate transcription

(2007) Sarah Ross et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY